143 related articles for article (PubMed ID: 11391863)
1. A pharmacological study of the weekday-on/weekend-off oral UFT schedule in colorectal cancer patients.
Sadahiro S; Suzuki T; Kameya T; Iwase H; Tajima T; Makuuchi H
Cancer Chemother Pharmacol; 2001 May; 47(5):457-60. PubMed ID: 11391863
[TBL] [Abstract][Full Text] [Related]
2. A novel weekday-on/weekend-off UFT schedule.
Sadahiro S; Makuuchi H; Suzuki T; Tokunaga N; Ishizu K; Tajima T
Oncology (Williston Park); 2000 Oct; 14(10 Suppl 9):87-90. PubMed ID: 11098503
[TBL] [Abstract][Full Text] [Related]
3. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
[TBL] [Abstract][Full Text] [Related]
4. [Feasibility of weekday-on/weekend-off oral UFT/Leucovorin schedule as postoperative adjuvant chemotherapy for colorectal cancer].
Sadahiro S; Suzuki T; Maeda Y; Makuuchi H; Murayama C
Gan To Kagaku Ryoho; 2006 Mar; 33(3):333-6. PubMed ID: 16531713
[TBL] [Abstract][Full Text] [Related]
5. Effect of food on the oral bioavailability of UFT and leucovorin in cancer patients.
Damle B; Ravandi F; Kaul S; Sonnichsen D; Ferreira I; Brooks D; Stewart D; Alberts D; Pazdur R
Clin Cancer Res; 2001 Mar; 7(3):517-23. PubMed ID: 11297242
[TBL] [Abstract][Full Text] [Related]
6. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer.
Borner MM; Schoffski P; de Wit R; Caponigro F; Comella G; Sulkes A; Greim G; Peters GJ; van der Born K; Wanders J; de Boer RF; Martin C; Fumoleau P
Eur J Cancer; 2002 Feb; 38(3):349-58. PubMed ID: 11818199
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of a novel weekday-on/weekend-off oral UFT schedule as postoperative adjuvant chemotherapy for colorectal cancer. UFT Compliance Study Group, Kanagawa, Japan.
Sadahiro S; Ohki S; Yamaguchi S; Takahashi T; Otani Y; Tsukikawa S; Yamamura T; Takemiya S; Nagasaki H; Nishiyama K; Fukushima T; Hiki Y; Yamaguchi S; Kumada K; Shimada H; Mitomi T; Makuuchi H
Cancer Chemother Pharmacol; 2000; 46(3):180-4. PubMed ID: 11021734
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.
Muggia FM; Wu X; Spicer D; Groshen S; Jeffers S; Leichman CG; Leichman L; Chan KK
Clin Cancer Res; 1996 Sep; 2(9):1461-7. PubMed ID: 9816321
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability and phase II study of oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ; Sonnichsen DS; Birkhofer MJ; Ferreira I; Noel D
Cancer Chemother Pharmacol; 1999; 43(3):221-6. PubMed ID: 9923552
[TBL] [Abstract][Full Text] [Related]
10. Dual antitumor effects of 5-fluorouracil on the cell cycle in colorectal carcinoma cells: a novel target mechanism concept for pharmacokinetic modulating chemotherapy.
Yoshikawa R; Kusunoki M; Yanagi H; Noda M; Furuyama JI; Yamamura T; Hashimoto-Tamaoki T
Cancer Res; 2001 Feb; 61(3):1029-37. PubMed ID: 11221829
[TBL] [Abstract][Full Text] [Related]
11. A clinical pharmacokinetic analysis of tegafur-uracil (UFT) plus leucovorin given in a new twice-daily oral administration schedule.
Etienne-Grimaldi MC; François E; Cardot JM; Renée N; Douillard JY; Gamelin E; Bennouna J; Château Y; Milano G
Clin Pharmacokinet; 2007; 46(11):953-63. PubMed ID: 17922560
[TBL] [Abstract][Full Text] [Related]
12. [Concentration of 5-fluorouracil in the blood and tissues of gastric and colo-rectal cancer patients after oral administration of UFT].
Inaba S; Kondo Y; Tsuchiya K; Kawai K; Ogino A; Umeda T; Ueda Y
Gan To Kagaku Ryoho; 1992 Nov; 19(13):2175-80. PubMed ID: 1444483
[TBL] [Abstract][Full Text] [Related]
13. Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer.
Meropol NJ; Noel D; Sonnichsen DS; Birkhofer MJ
Oncology (Williston Park); 1997 Sep; 11(9 Suppl 10):22-5. PubMed ID: 9348562
[TBL] [Abstract][Full Text] [Related]
14. UFT and leucovorin: a review of its clinical development and therapeutic potential in the oral treatment of cancer.
Hoff PM; Pazdur R; Benner SE; Canetta R
Anticancer Drugs; 1998 Jul; 9(6):479-90. PubMed ID: 9877235
[TBL] [Abstract][Full Text] [Related]
15. [Pre- and post-operative adjuvant chemotherapy of colorectal cancer. Part 1. Drug concentration in tissues following UFT administration].
Tomita M; Shimoyama T; Hirano T; Nakagoe T; Shimizu T; Kusano H; Fukuda Y; Eida K; Ishii T; Kotake Y
Gan To Kagaku Ryoho; 1988 Dec; 15(12):3239-43. PubMed ID: 3143310
[TBL] [Abstract][Full Text] [Related]
16. [Studies on tissue concentration of tegafur, 5-fluorouracil, uracil after UFT administration together with the study of microangiography of colorectal cancer].
Shimoyama T; Shimizu T; Kusano H; Ishikawa H; Miyashita K; Nakazaki T; Yasutake T; Yoshida A; Yoshida K; Ogawa T
Gan To Kagaku Ryoho; 1993 Jan; 20(1):125-30. PubMed ID: 8422176
[TBL] [Abstract][Full Text] [Related]
17. [Drug concentration in cancerous large bowel tissue and thymidylate synthase inhibition rate after administration of tegafur and UFT].
Futami K; Arima S; Yoshimura S; Okamoto T; Yamasaki K; Koto T; Yamasaki S; Kawahara K; Ikuno T
Gan To Kagaku Ryoho; 1991 Feb; 18(2):215-20. PubMed ID: 1992915
[TBL] [Abstract][Full Text] [Related]
18. Results of pharmacokinetic modulating chemotherapy in combination with hepatic arterial 5-fluorouracil infusion and oral UFT after resection of hepatic colorectal metastases.
Kusunoki M; Yanagi H; Noda M; Yoshikawa R; Yamamura T
Cancer; 2000 Sep; 89(6):1228-35. PubMed ID: 11002217
[TBL] [Abstract][Full Text] [Related]
19. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.
Douillard JY; Hoff PM; Skillings JR; Eisenberg P; Davidson N; Harper P; Vincent MD; Lembersky BC; Thompson S; Maniero A; Benner SE
J Clin Oncol; 2002 Sep; 20(17):3605-16. PubMed ID: 12202661
[TBL] [Abstract][Full Text] [Related]
20. [Pharmacokinetic study of UFT in cancer patients receiving maintenance dialysis].
Sakamoto K; Arita S; Hisikawa E; Yaguchi H; Arima H; Matsumoto M; Hachisu T; Kashiwabara H; Yokoyama T
Gan To Kagaku Ryoho; 1995 Feb; 22(2):239-44. PubMed ID: 7857099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]